Oral alkaline phosphatase (Synthetic Biologics)

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameOral alkaline phosphatase (Synthetic Biologics)
Drug Alias NameOral intestinal alkaline phosphatase (Synthetic Biologics)SYN-020
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionIntestinal alkaline phosphatase replacements
TargetsIntestinal alkaline phosphatase
Therapy Area/IndicationsMetabolic SyndromeCeliac DiseaseInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheriva Biologics IncMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesRasayana Therapeutics IncTheriva Biologics Inc
Inactive CompaniesN/A
Active IndicationsMetabolic SyndromeCeliac DiseaseInflammatory Bowel Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A